drugset / Trial / NCT07225647

A Study to Assess the Effect of Food on the Drug Levels of Admilparant

NCT07225647

Phase 1 Completed 56 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of food on the drug levels of Admilparant

Timeline

Start
2025-11-07
Primary completion
2026-01-05
Completion
2026-01-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Admilparant Small molecule

Indications

No indication recorded.